Evidence map›Paper›PMID 32488126›Full record

ArticleMolecular psychiatry2021

Pre-deployment risk factors for PTSD in active-duty personnel deployed to Afghanistan: a machine-learning approach for analyzing multivariate predictors.

Katharina Schultebraucks, Meng Qian, Duna Abu-Amara, Kelsey Dean, Eugene Laska, Carole Siegel, Aarti Gautam, Guia Guffanti, Rasha Hammamieh, Burook Misganaw and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Pre-trauma cognitive traits predict fear generalization and associated prefrontal functioning in a longitudinal rodent model.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Katharina SchultebraucksDepartment of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA. ks3796@cumc.columbia.edu.ORCID http://orcid.org/0000-0001-5085-8249
Meng QianDepartment of Psychiatry, Center for Alcohol Use Disorder and PTSD, New York University Grossman School of Medicine, New York, NY, USA.
Duna Abu-AmaraDepartment of Psychiatry, Center for Alcohol Use Disorder and PTSD, New York University Grossman School of Medicine, New York, NY, USA.
Kelsey DeanHarvard Paulson School of Engineering & Applied Sciences, Boston, MA, USA.
Eugene LaskaDepartment of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
Carole SiegelDepartment of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-7460-788X
Aarti GautamIntegrative Systems Biology, US Army Center for Environmental Health Research, USACEHR, Fort Detrick, Frederick, MD, USA.
Guia GuffantiMcLean Hospital, Harvard University, Boston, MA, USA.
Rasha HammamiehIntegrative Systems Biology, US Army Center for Environmental Health Research, USACEHR, Fort Detrick, Frederick, MD, USA.
Burook MisganawHarvard Paulson School of Engineering & Applied Sciences, Boston, MA, USA.
Synthia H MellonDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, CA, USA.
Owen M WolkowitzDepartment of Psychiatry/Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
Esther M BlessingDepartment of Psychiatry, Center for Alcohol Use Disorder and PTSD, New York University Grossman School of Medicine, New York, NY, USA.
Amit EtkinAlto Neuroscience, Inc., Los Altos, CA, USA.
Kerry J ResslerMcLean Hospital, Harvard University, Boston, MA, USA.
Francis J DoyleHarvard Paulson School of Engineering & Applied Sciences, Boston, MA, USA.
Marti JettIntegrative Systems Biology, US Army Center for Environmental Health Research, USACEHR, Fort Detrick, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-2899-0216
Charles R MarmarDepartment of Psychiatry, Center for Alcohol Use Disorder and PTSD, New York University Grossman School of Medicine, New York, NY, USA.
New York University · USUnited States Army Corps of Engineers · USHarvard University · USUniversity of California, San Francisco · USColumbia University Irving Medical Center · USNeurosciences Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Active-duty Army personnel can be exposed to traumatic warzone events and are at increased risk for developing post-traumatic stress disorder (PTSD) compared with the general population. PTSD is associated with high individual and societal costs, but identification of predictive markers to determine deployment readiness and risk mitigation strategies is not well understood. This prospective longitudinal naturalistic cohort study-the Fort Campbell Cohort study-examined the value of using a large multidimensional dataset collected from soldiers prior to deployment to Afghanistan for predicting post-deployment PTSD status. The dataset consisted of polygenic, epigenetic, metabolomic, endocrine, inflammatory and routine clinical lab markers, computerized neurocognitive testing, and symptom self-reports. The analysis was computed on active-duty Army personnel (N = 473) of the 101st Airborne at Fort Campbell, Kentucky. Machine-learning models predicted provisional PTSD diagnosis 90-180 days post deployment (random forest: AUC = 0.78, 95% CI = 0.67-0.89, sensitivity = 0.78, specificity = 0.71; SVM: AUC = 0.88, 95% CI = 0.78-0.98, sensitivity = 0.89, specificity = 0.79) and longitudinal PTSD symptom trajectories identified with latent growth mixture modeling (random forest: AUC = 0.85, 95% CI = 0.75-0.96, sensitivity = 0.88, specificity = 0.69; SVM: AUC = 0.87, 95% CI = 0.79-0.96, sensitivity = 0.80, specificity = 0.85). Among the highest-ranked predictive features were pre-deployment sleep quality, anxiety, depression, sustained attention, and cognitive flexibility. Blood-based biomarkers including metabolites, epigenomic, immune, inflammatory, and liver function markers complemented the most important predictors. The clinical prediction of post-deployment symptom trajectories and provisional PTSD diagnosis based on pre-deployment data achieved high discriminatory power. The predictive models may be used to determine deployment readiness and to determine novel pre-deployment interventions to mitigate the risk for deployment-related PTSD.

Indexed as

Military PersonnelStress Disorders, Post-TraumaticAfghanistanCohort StudiesHumansMachine LearningProspective StudiesRisk FactorsSleep Quality

Identifiers

PMID32488126
PMCPMC8589682
OpenAlexW3028774941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.